2241-PMC306 (Lecture 06)
2241-PMC306 (Lecture 06)
2241-PMC306 (Lecture 06)
Tetracyclines
3
Tetracyclines
Spectrum & Uses
Tetracyclines are broad spectrum antibiotics which also can be
used for:
• Malarial infections
• Intestinal amoebiasis & bacillary dysentery
• Acne
MOA
• Tetracyclines are PROTEIN SYNTHESIS INHIBITORS (Bacteriostatic)
Naphthacene Octahydronaphthacene
(9 double bonds) (5 double bonds)
5
3ry
Alcohol 4𝛂-dimethyl
amino
Enolic
Alcohol
Aromatic
Ring D
Phenolic OH
Ketone
Amide
Enolic
Alcohol
6
4𝛂-dimethyl
amino
Basic
pKa of conj. Acid = 9.7
Acidic
Amide pKa = 3.3
7
Ketone and alcohol can chelate metal ions → Insoluble non-absorbable chelate
α-configuration β-configuration
4-Epitetracycline
Inactive
9
Chemical Instability
C C
Anhydrotetracycline
Inactive
10
Chemical Instability
Inactive
Nephrotoxic
4-Epianhydrotetracycline
11
Chemical Instability
Isotetracycline
Inactive
12
Natural Tetracyclines
Unstable to strong acids and bases
with 6-OH
Tetracycline
• Oral
• Low cost
• Unstable (why?)
• Used for Acne
14
Natural Tetracyclines
7-Cl increases
Chlortetracycline lipophilicity & activity
Doxycycline
• Used orally.
• Has less GIT disturbances.
• In patients with uremia or significantly impaired kidney function, doxycycline is often a preferred
tetracycline antibiotic because it undergoes hepatic rather than renal elimination. Unlike other
tetracyclines, doxycycline’s excretion does not heavily rely on the kidneys, so it doesn’t accumulate to
toxic levels in uremic patients.
17
Semisynthetic Tetracyclines
Doxycycline
Semi-synthesis
H2
DMF
[Dimethylformamide]
oxytetracycline Doxycycline
18
Aminoglycosides
19
Aminoglycosides
Glycosides of Amino Sugars
Glycosidic Bond
20
Streptidine
Streptamine
2-Deoxy
Streptamine
Spectinamine
22
Streptomycin
Selman Waksman
Nobel Prize in Medicine 1952
25
Streptidine
[Aglycone]
N-methyl Glucosamine
[amino sugar]
Streptose
Aldehyde Group [Neutral sugar]
26
(2) 2-Deoxy Streptamine Derivatives
Sugar Sugar
Kanamycin
2-Deoxy Streptamine
Kanamycin A
Due to its toxicity and resistance concerns, kanamycin is typically reserved for
situations where other antibiotics are ineffective.
27
Kanamycin Bacterial Resistance
R-factors are plasmids that carry genes encoding for enzymes that confer resistance to various
R-Factor Mediated Enzymes antibiotics, including kanamycin. These enzymes are typically aminoglycoside-modifying
enzymes, and they alter kanamycin's structure, preventing it from binding to bacterial
ribosomes and inhibiting protein synthesis.
Ph
Ac
Ac
28
(2) 2-Deoxy Streptamine Derivatives
Tobramycin
Decreased resistance by Absence of
targeted functional group
Used parenterally for Pseudomonas
infections.
Used by inhalation for Pseudomonas
infections in cystic fibrosis patients
[this route decreases toxicity]
Gentamicin
Decreased resistance by
Absence of targeted functional group
Used parenterally for
Pseudomonas infections
[Pneumonia, Urinary Tract
Infections UTI]
Broader spectrum
> Kanamycin
Incompatibility of aminoglycosides with 𝛃–lactam antibiotics 31
Consequences
Loss of Efficacy: The inactivation of the beta-lactam antibiotic leads to reduced antibacterial activity,.
Reduced Aminoglycoside Potency: The aminoglycoside may also lose some of its effectiveness due to chemical interaction.
Chloramphenicol
34
Chloramphenicol
Bacteriostatic
35
Spectrum & Indications
Adverse Effects
Chloramphenicol Palmitate
Form: Oral suspension (commonly used for pediatric
formulations).
Purpose: Designed to improve palatability and
stability for oral use. Chloramphenicol palmitate is
insoluble in water, making it less bitter and better
suited for children.
Chloramphenicol Hemisuccinate